Cargando…

Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system

BACKGROUND: The Musculoskeletal Tumor Society (MSTS) scoring system is a disease-specific instrument to determine the physical and mental health for patients with extremity sarcoma. This study aims to investigate the reliability and validity of the Chinese version of the MSTS, and to evaluate functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Leilei, Li, Xinhua, Wang, Zhou, Xiong, Jin, Wang, Shoufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438502/
https://www.ncbi.nlm.nih.gov/pubmed/28526051
http://dx.doi.org/10.1186/s12955-017-0685-x
_version_ 1783237775488712704
author Xu, Leilei
Li, Xinhua
Wang, Zhou
Xiong, Jin
Wang, Shoufeng
author_facet Xu, Leilei
Li, Xinhua
Wang, Zhou
Xiong, Jin
Wang, Shoufeng
author_sort Xu, Leilei
collection PubMed
description BACKGROUND: The Musculoskeletal Tumor Society (MSTS) scoring system is a disease-specific instrument to determine the physical and mental health for patients with extremity sarcoma. This study aims to investigate the reliability and validity of the Chinese version of the MSTS, and to evaluate functional outcomes of the surgical treatment of lower extremity sarcoma using the Chinese MSTS. METHODS: A cohort of 98 patients who had undergone surgery for lower extremity sarcoma were included. All the patients completed the clinical assessment with the Chinese MSTS and the Chinese Toronto Extremity Salvage Score (TESS). Assessment of psychometric properties was carried out through reliability and validity test. The reliability of Chinese MSTS was evaluated through test-retest analysis, inter-observer analysis and internal consistency. The inter-observer and test-retest reliability was analyzed with intra-class correlation coefficient (ICC). The internal consistency was evaluated by Cronbach’s α, with a value >0.70 considered acceptable. The discriminant validity was evaluated through comparison of the MSTS score between patients undergoing amputation surgeries and those undergoing limb-salvage surgeries. The construct validity was evaluated with the factor analysis. RESULTS: The mean MSTS score was 21.5 ± 7.1. The ICC was 0.91 (95% confidence interval (CI) = 0.85–0.96) for the test-retest reliability and 0.90 (95% CI = 0.86–0.93) for the inter-observer analysis. The test for internal consistency showed a Cronbach’s α of 0.86 for the MSTS. Patients undergoing amputation surgery had remarkably lower MSTS score than patients undergoing limb-salvage surgeries (18.8 ± 5.4 vs. 23.5 ± 6.3, p = 0.005), which indicated a good discrinimant validity of the Chinese MSTS. The factor analysis indicated a 1-factor model with acceptable goodness of fit. CONCLUSIONS: The Chinese MSTS scoring system is a reliable and valid instrument with well-accepted psychometric properties. Through application of the Chinese MSTS, we demonstrated that patients receiving limb-salvage surgeries may have better functional outcome and QoL than those undergoing amputation surgeries. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-017-0685-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5438502
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54385022017-05-22 Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system Xu, Leilei Li, Xinhua Wang, Zhou Xiong, Jin Wang, Shoufeng Health Qual Life Outcomes Research BACKGROUND: The Musculoskeletal Tumor Society (MSTS) scoring system is a disease-specific instrument to determine the physical and mental health for patients with extremity sarcoma. This study aims to investigate the reliability and validity of the Chinese version of the MSTS, and to evaluate functional outcomes of the surgical treatment of lower extremity sarcoma using the Chinese MSTS. METHODS: A cohort of 98 patients who had undergone surgery for lower extremity sarcoma were included. All the patients completed the clinical assessment with the Chinese MSTS and the Chinese Toronto Extremity Salvage Score (TESS). Assessment of psychometric properties was carried out through reliability and validity test. The reliability of Chinese MSTS was evaluated through test-retest analysis, inter-observer analysis and internal consistency. The inter-observer and test-retest reliability was analyzed with intra-class correlation coefficient (ICC). The internal consistency was evaluated by Cronbach’s α, with a value >0.70 considered acceptable. The discriminant validity was evaluated through comparison of the MSTS score between patients undergoing amputation surgeries and those undergoing limb-salvage surgeries. The construct validity was evaluated with the factor analysis. RESULTS: The mean MSTS score was 21.5 ± 7.1. The ICC was 0.91 (95% confidence interval (CI) = 0.85–0.96) for the test-retest reliability and 0.90 (95% CI = 0.86–0.93) for the inter-observer analysis. The test for internal consistency showed a Cronbach’s α of 0.86 for the MSTS. Patients undergoing amputation surgery had remarkably lower MSTS score than patients undergoing limb-salvage surgeries (18.8 ± 5.4 vs. 23.5 ± 6.3, p = 0.005), which indicated a good discrinimant validity of the Chinese MSTS. The factor analysis indicated a 1-factor model with acceptable goodness of fit. CONCLUSIONS: The Chinese MSTS scoring system is a reliable and valid instrument with well-accepted psychometric properties. Through application of the Chinese MSTS, we demonstrated that patients receiving limb-salvage surgeries may have better functional outcome and QoL than those undergoing amputation surgeries. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-017-0685-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-19 /pmc/articles/PMC5438502/ /pubmed/28526051 http://dx.doi.org/10.1186/s12955-017-0685-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Xu, Leilei
Li, Xinhua
Wang, Zhou
Xiong, Jin
Wang, Shoufeng
Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system
title Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system
title_full Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system
title_fullStr Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system
title_full_unstemmed Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system
title_short Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system
title_sort functional evaluation for patients with lower extremity sarcoma: application of the chinese version of musculoskeletal tumor society scoring system
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438502/
https://www.ncbi.nlm.nih.gov/pubmed/28526051
http://dx.doi.org/10.1186/s12955-017-0685-x
work_keys_str_mv AT xuleilei functionalevaluationforpatientswithlowerextremitysarcomaapplicationofthechineseversionofmusculoskeletaltumorsocietyscoringsystem
AT lixinhua functionalevaluationforpatientswithlowerextremitysarcomaapplicationofthechineseversionofmusculoskeletaltumorsocietyscoringsystem
AT wangzhou functionalevaluationforpatientswithlowerextremitysarcomaapplicationofthechineseversionofmusculoskeletaltumorsocietyscoringsystem
AT xiongjin functionalevaluationforpatientswithlowerextremitysarcomaapplicationofthechineseversionofmusculoskeletaltumorsocietyscoringsystem
AT wangshoufeng functionalevaluationforpatientswithlowerextremitysarcomaapplicationofthechineseversionofmusculoskeletaltumorsocietyscoringsystem